Retatrutide, developed by Soma Chems , is gaining increasing attention as a innovative method for metabolic control . This unique medication merges the mechanism of a GLP-1 receptor stimulant and a GIP receptor agonist , intended to simply promote reduced body fat but also target underlying metab